Ragosa Mark
Reporting owner on Forms 3, 4 and 5, CIK 1835458.
Ragosa Mark reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-11-03.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| KNSA · Kiniksa Pharmaceuticals International, plcCIK 1730430 | officer (CHIEF FINANCIAL OFFICER) | 1 | 2026-11-03 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share | 2026-11-02 | M exercised | +9,636 | $10.76 | 30,490 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share | 2026-11-02 | M exercised | +5,388 | $11.1 | 35,878 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share | 2026-11-02 | M exercised | +12,123 | $11.97 | 48,001 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share | 2026-11-02 | M exercised | +9,636 | $17.76 | 57,637 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share | 2026-11-02 | S sold | -14,027 | $91.4 | 43,610 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share | 2026-11-02 | S sold | -10,502 | $92.03 | 33,108 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share | 2026-11-02 | S sold | -12,034 | $93.13 | 21,074 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share | 2026-11-02 | S sold | -220 | $94.01 | 20,854 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Share Option, derivative | 2026-11-02 | M exercised | -9,636 | $0 | 4,380 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Share Option, derivative | 2026-11-02 | M exercised | -5,388 | $0 | 0 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Share Option, derivative | 2026-11-02 | M exercised | -12,123 | $0 | 0 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Share Option, derivative | 2026-11-02 | M exercised | -9,636 | $0 | 8,760 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001835458-26-000014 | Kiniksa Pharmaceuticals International, plc | 2026-11-03 |